|
1
|
Louis CU and Shohet JM: Neuroblastoma:
Molecular pathogenesis and therapy. Annu Rev Med. 66:49–63. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pinto NR, Applebaum MA, Volchenboum SL,
Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F,
Schleiermacher G, Park JR, et al: Advances in risk classification
and treatment strategies for neuroblastoma. J Clin Oncol.
33:3008–3017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
PDQ Pediatric Treatment Editorial Board:
Neuroblastoma treatment (PDQ(R)): Health professional version. PDQ
cancer information summaries, Bethesda (MD). 2002.
|
|
4
|
Luksch R, Castellani MR, Collini P, de
Bernardi B, Conte M, Gambini C, Gandola L, Garaventa A, Biasoni D,
Podda M, et al: Neuroblastoma (peripheral neuroblastic tumours).
Crit Rev Oncol Hematol. 107:163–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huynh MH, Sage EH and Ringuette M: A
calcium-binding motif in SPARC/osteonectin inhibits chordomesoderm
cell migration during xenopus laevis gastrulation: Evidence of
counter-adhesive activity in vivo. Dev Growth Differ. 41:407–418.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clark CJ and Sage EH: A prototypic
matricellular protein in the tumor microenvironment-where there's
SPARC, there's fire. J Cell Biochem. 104:721–732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagaraju GP and Sharma D: Anti-cancer role
of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev.
37:559–566. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han W, Cao F, Chen MB, Lu RZ, Wang HB, Yu
M, Shi CT and Ding HZ: Prognostic value of SPARC in patients with
pancreatic cancer: A systematic review and meta-analysis. PLoS One.
11:e01458032016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng J and Tang L: SPARC in tumor
pathophysiology and as a potential therapeutic target. Curr Pharm
Des. 20:6182–6190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Said N and Motamed K: Absence of
host-secreted protein acidic and rich in cysteine (SPARC) augments
peritoneal ovarian carcinomatosis. Am J Pathol. 167:1739–1752.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang MJ and Tai IT: A novel interaction
between procaspase 8 and SPARC enhances apoptosis and potentiates
chemotherapy sensitivity in colorectal cancers. J Biol Chem.
282:34457–34467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chlenski A, Guerrero LJ, Peddinti R, Spitz
JA, Leonhardt PT, Yang Q, Tian Y, Salwen HR and Cohn SL:
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma
tumors. Mol Cancer. 9:1382010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhoopathi P, Chetty C, Gujrati M, Dinh DH,
Rao JS and Lakka S: Cathepsin B facilitates autophagy mediated
apoptosis in SPARC overexpressed primitive neuroectodermal tumor
cells. Cell Death Differ. 17:1529–1539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhoopathi P, Gorantla B, Sailaja GS, Gondi
CS, Gujrati M, Klopfenstein JD and Rao JS: SPARC overexpression
inhibits cell proliferation in neuroblastoma and is partly mediated
by tumor suppressor protein PTEN and AKT. PLoS One. 7:e360932012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Golembieski WA, Thomas SL, Schultz CR,
Yunker CK, McClung HM, Lemke N, Cazacu S, Barker T, Sage EH, Brodie
C and Rempel SA: HSP27 mediates SPARC-induced changes in glioma
morphology, migration, and invasion. Glia. 56:1061–1075. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blattes GB, Mestieri LB, Böttcher DE,
Fossati AC, Montagner F and Grecca FS: Cell migration, viability
and tissue reaction of calcium hypochlorite based-solutions
irrigants: An in vitro and in vivo study. Arch Oral Biol. 73:34–39.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grada A, Otero-Vinas M, Prieto-Castrillo
F, Obagi Z and Falanga V: Research techniques made simple: Analysis
of collective cell migration using the wound healing assay. J
Invest Dermatol. 137:e11–e16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salvioli S, Dobrucki J, Moretti L, Troiano
L, Fernandez MG, Pinti M, Pedrazzi J, Franceschi C and Cossarizza
A: Mitochondrial heterogeneity during staurosporine-induced
apoptosis in HL60 cells: Analysis at the single cell and single
organelle level. Cytometry. 40:189–197. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Perchellet EM, Ward MM, Lou K, Hua
DH and Perchellet JP: Rapid collapse of mitochondrial transmembrane
potential in HL-60 cells and isolated mitochondria treated with
anti-tumor 1,4-anthracenediones. Anticancer Drugs. 16:953–967.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hawley-Nelson P and Ciccarone V:
Transfection of cultured eukaryotic cells using cationic lipid
reagents. Curr Protoc Neurosci Appendix. 1:Appendix 1F. 2001.
View Article : Google Scholar
|
|
21
|
Paul CA, Beltz B and Berger-Sweeney J:
Subbing slides. CSH Protoc. 2008:pdb.prot4804. 2008.
|
|
22
|
Chadderton T, Wilson C, Bewick M and Glück
S: Evaluation of three rapid RNA extraction reagents: Relevance for
use in RT-PCR's and measurement of low level gene expression in
clinical samples. Cell Mol Biol (Noisy-le-Grand). 43:1227–1234.
1997.PubMed/NCBI
|
|
23
|
Mi H, Muruganujan A, Casagrande JT and
Thomas PD: Large-scale gene function analysis with the PANTHER
classification system. Nat Protoc. 8:1551–1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lane TF and Sage EH: The biology of SPARC,
a protein that modulates cell-matrix interactions. FASEB J.
8:163–173. 1994.PubMed/NCBI
|
|
25
|
Porter PL, Sage EH, Lane TF, Funk SE and
Gown AM: Distribution of SPARC in normal and neoplastic human
tissue. J Histochem Cytochem. 43:791–800. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gorantla B, Bhoopathi P, Chetty C,
Gogineni VR, Sailaja GS, Gondi CS and Rao JS: Notch signaling
regulates tumor-induced angiogenesis in SPARC-overexpressed
neuroblastoma. Angiogenesis. 16:85–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ribatti D: Anti-angiogenesis in
neuroblastoma. Crit Rev Oncol Hematol. 86:212–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arya R, Mallik M and Lakhotia SC: Heat
shock genes-integrating cell survival and death. J Biosci.
32:595–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bao XQ and Liu GT: Bicyclol protects HepG2
cells against D-galactosamine-induced apoptosis through inducing
heat shock protein 27 and mitochondria associated pathway. Acta
Pharmacol Sin. 31:219–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pandey P, Farber R, Nakazawa A, Kumar S,
Bharti A, Nalin C, Weichselbaum R, Kufe D and Kharbanda S: Hsp27
functions as a negative regulator of cytochrome c-dependent
activation of procaspase-3. Oncogene. 19:1975–1981. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li R, Li J, Sang D and Lan Q:
Phosphorylation of AKT induced by phosphorylated Hsp27 confers the
apoptosis-resistance in t-AUCB-treated glioblastoma cells in vitro.
J Neurooncol. 121:83–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsu HS, Lin JH, Huang WC, Hsu TW, Su K,
Chiou SH, Tsai YT and Hung SC: Chemoresistance of lung cancer
stemlike cells depends on activation of Hsp27. Cancer.
117:1516–1528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang B, Zhou HS, Cheng Q, Lei L and Hu B:
Overexpression of HSP27 in cultured human aortic smooth muscular
cells reduces apoptosis induced by low-frequency and low-energy
ultrasound by inhibition of an intrinsic pathway. Genet Mol Res.
12:6588–6601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guttmann DM, Hart L, Du K, Seletsky A and
Koumenis C: Inhibition of Hsp27 radiosensitizes head-and-neck
cancer by modulating deoxyribonucleic acid repair. Int J Radiat
Oncol Biol Phys. 87:168–175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guo Y, Ziesch A, Hocke S, Kampmann E, Ochs
S, de Toni EN, Göke B and Gallmeier E: Overexpression of heat shock
protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic
cancer cells through S-phase arrest and apoptosis. J Cell Mol Med.
19:340–350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang S, Zhang XQ, Huang SL, Chen M, Shen
SS, Ding XW, Lv Y and Zou XP: The effects of HSP27 on
gemcitabine-resistant pancreatic cancer cell line through snail.
Pancreas. 44:1121–1129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
O'Callaghan-Sunol C, Gabai VL and Sherman
MY: Hsp27 modulates p53 signaling and suppresses cellular
senescence. Cancer Res. 67:11779–11788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sailaja GS, Bhoopathi P, Gorantla B,
Chetty C, Gogineni VR, Velpula KK, Gondi CS and Rao JS: The
secreted protein acidic and rich in cysteine (SPARC) induces
endoplasmic reticulum stress leading to autophagy-mediated
apoptosis in neuroblastoma. Int J Oncol. 42:188–196.
2013.PubMed/NCBI
|
|
39
|
Fulda S: Targeting apoptosis for
anticancer therapy. Semin Cancer Biol. 31:84–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim B, Srivastava SK and Kim SH: Caspase-9
as a therapeutic target for treating cancer. Expert Opin Ther
Targets. 19:113–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
